PlainRecalls
FDA Drug Moderate Class II Terminated

Venlafaxine Hydrochloride Extended-Release Capsules, USP 37.5mg, packaged in a) 90-count bottles (NDC 68382-034-16) and b)1000-count bottles (NDC 68382-034-10), Rx only, Mfg. by: Zydus Lifesciences Ltd. Ahmedabad, India; Dist. by: Zydus Pharmaceuticals (USA) Inc. Pennington, NJ 08534

Reported: July 31, 2024 Initiated: June 21, 2024 #D-0617-2024

Product Description

Venlafaxine Hydrochloride Extended-Release Capsules, USP 37.5mg, packaged in a) 90-count bottles (NDC 68382-034-16) and b)1000-count bottles (NDC 68382-034-10), Rx only, Mfg. by: Zydus Lifesciences Ltd. Ahmedabad, India; Dist. by: Zydus Pharmaceuticals (USA) Inc. Pennington, NJ 08534

Reason for Recall

Failed Dissolution Specifications: Out-of-specification results observed for dissolution testing at the 8-hour and 12-hour pull intervals.

Details

Units Affected
a) 13,128 bottles; b) 252 bottles
Distribution
Nationwide within the United States
Location
Pennington, NJ

Frequently Asked Questions

What product was recalled?
Venlafaxine Hydrochloride Extended-Release Capsules, USP 37.5mg, packaged in a) 90-count bottles (NDC 68382-034-16) and b)1000-count bottles (NDC 68382-034-10), Rx only, Mfg. by: Zydus Lifesciences Ltd. Ahmedabad, India; Dist. by: Zydus Pharmaceuticals (USA) Inc. Pennington, NJ 08534. Recalled by Zydus Pharmaceuticals (USA) Inc. Units affected: a) 13,128 bottles; b) 252 bottles.
Why was this product recalled?
Failed Dissolution Specifications: Out-of-specification results observed for dissolution testing at the 8-hour and 12-hour pull intervals.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 31, 2024. Severity: Moderate. Recall number: D-0617-2024.